Home
Conditions
Hepatitis

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

NCT00473668

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Kolkotta, India

GSK Investigational Site Varanasi, India

View Trial Details

Completed

Integrating HIV and Hepatitis C Screening in an Urban Emergency Department

NCT03252483

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +23 more
Locations: Jacobi Medical Center The Bronx, New York, United States

View Trial Details

Completed

Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection

NCT02027116

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pusan National University Hospital Pusan, South Korea

Yonsei University Severance Hospital Seoul, South Korea

View Trial Details

Completed

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

NCT01353742

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Shatin, New Territories, Hong Kong

View Trial Details

Completed

Hepatitis C Antiviral Resistance in African-Americans

NCT00038974

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University of California, San Francisco San Francisco, California, United States

University of Miami School of Medicine Miami, Florida, United States

Rush University Chicago, Illinois, United States

University of Maryland School of Medicine Baltimore, Maryland, United States

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

NCT02442271

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

NCT02624063

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Outpatient Clinic of Viral Hepatitis (NUPAIG) São Paulo, Brazil

View Trial Details

Completed

Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

NCT02562742

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Ageo-shi, Japan

Bunkyō City, Japan

Chuo-shi, Japan

Fujioka-shi, Japan

View all 45 locations

View Trial Details

Completed

Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults

NCT01458054

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Completed

Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805

NCT01424540

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: GSK Investigational Site Buffalo, New York, United States

View Trial Details

Hepatitis

Hepatitis trial results

Related conditions